| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1479-828X.2000.TB01136.X |
| P698 | PubMed publication ID | 10925899 |
| P50 | author | Michael Peek | Q42666310 |
| Lesley McCowan | Q52158988 | ||
| P2093 | author name string | J Higgins | |
| J A Rowan | |||
| M A Brown | |||
| W M Hague | |||
| S Lowe | |||
| J Oats | |||
| B N Walters | |||
| Australasian Society for the Study of Hypertension in Pregnancy | |||
| P433 | issue | 2 | |
| P921 | main subject | hypertension | Q95566669 |
| P304 | page(s) | 133-138 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Australian and New Zealand Journal of Obstetrics and Gynaecology | Q15764794 |
| P1476 | title | The detection, investigation and management of hypertension in pregnancy: executive summary | |
| P478 | volume | 40 |
| Q49351506 | A Randomized Double-Blinded Placebo-Controlled Intervention Trial of Melatonin for the Prevention of Preeclampsia in Moderate- and High-Risk Women: The MELPOP Trial |
| Q33439319 | A current landscape of provincial perinatal data collection in Canada |
| Q34085771 | A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy |
| Q35888426 | A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia |
| Q44874950 | A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy |
| Q50142536 | A survey of canadian practitioners regarding diagnosis and evaluation of the hypertensive disorders of pregnancy |
| Q41091522 | Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age. |
| Q33301509 | An international benchmarking collaboration: measuring outcomes for the hypertensive disorders of pregnancy |
| Q64075036 | Analysis of the Epigenome in Multiplex Pre-eclampsia Families Identifies , , and as Novel Candidate Risk Genes |
| Q58623879 | Approach to Hypertensive Emergencies in Pregnancy |
| Q92930381 | Association Study of Single Nucleotide Polymorphisms of Endoplasmic Reticulum Aminopeptidase 1 and 2 Genes in Iranian Women with Preeclampsia |
| Q37186214 | Association between World Health Organization categories of body mass index and relative risks for weight-related pregnancy outcomes: a retrospective cohort study |
| Q53363409 | Calcium channel blockers prevent endothelial cell activation in response to necrotic trophoblast debris: possible relevance to pre-eclampsia. |
| Q38080492 | Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis |
| Q34936330 | Clinical prediction in early pregnancy of infants small for gestational age by customised birthweight centiles: findings from a healthy nulliparous cohort |
| Q37385224 | Comparison of lipid profile parameters and oxidized low-density lipoprotein between normal and preeclamptic pregnancies in a tertiary care hospital in Nepal |
| Q52938648 | Cuff width influence on blood pressure measurement during the pregnant-puerperal cycle. |
| Q33377706 | Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes |
| Q59521426 | Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study |
| Q33327641 | Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review |
| Q48259282 | Effect of urine creatinine level during pregnancy on dipstick test |
| Q41109963 | Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide. |
| Q46857607 | Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial |
| Q38816663 | Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis |
| Q47226020 | Estimation of fetal weight by ultrasound |
| Q54761246 | Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia. |
| Q50682567 | First trimester multivitamin/mineral use is associated with reduced risk of pre-eclampsia among overweight and obese women. |
| Q33712068 | Genetic and molecular functional characterization of variants within TNFSF13B, a positional candidate preeclampsia susceptibility gene on 13q |
| Q36950133 | Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease |
| Q30847534 | Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia. |
| Q34202996 | Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene |
| Q35641606 | Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. |
| Q35219641 | How to manage hypertension in pregnancy effectively |
| Q35566921 | Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis |
| Q33935105 | Increased decidual mRNA expression levels of candidate maternal pre-eclampsia susceptibility genes are associated with clinical severity |
| Q39490194 | Intrauterine growth restriction and the innate immune system in preterm infants of ≤32 weeks gestation |
| Q40784096 | Isolated gestational proteinuria preceding the diagnosis of preeclampsia - an observational study |
| Q35218424 | Maternal and fetal outcome of pregnancy related hypertension in Mettu Karl Referral Hospital, Ethiopia |
| Q37426466 | Maternal and perinatal outcome in obese pregnant patients |
| Q89863319 | Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study |
| Q36577103 | Mechanisms of disease: Pre-eclampsia |
| Q38009738 | Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy |
| Q24248046 | Oral beta-blockers for mild to moderate hypertension during pregnancy |
| Q38538243 | Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis |
| Q39380099 | Overexpression of calreticulin in pre-eclamptic placentas: effect on apoptosis, cell invasion and severity of pre-eclampsia |
| Q35823635 | Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers |
| Q81446389 | Pre-eclampsia |
| Q58328527 | Predicting Transformation from Gestational Hypertension to Preeclampsia in Clinical Practice: A Possible Role for 24 Hour Ambulatory Blood Pressure Monitoring |
| Q36752103 | Preeclampsia and future cardiovascular risk. |
| Q24197820 | Prevention and treatment of postpartum hypertension |
| Q24244776 | Prevention and treatment of postpartum hypertension |
| Q24248147 | Prevention and treatment of postpartum hypertension |
| Q43793017 | Problems in methods for the detection of significant proteinuria in pregnancy |
| Q36951149 | Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination |
| Q33746837 | Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. |
| Q94337208 | Setting and techniques for monitoring blood pressure during pregnancy |
| Q37141480 | Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. |
| Q34990788 | The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations |
| Q91997571 | The potential role of pregnancy-associated plasma protein-A2 in angiogenesis and development of preeclampsia |
| Q35609745 | The safety of antihypertensives for treatment of pregnancy hypertension |
| Q51156081 | Time poor: rushing decreases the accuracy and reliability of blood pressure measurement technique in pregnancy. |
| Q34257837 | Treating hypertension in women of child-bearing age and during pregnancy |
| Q30530225 | Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia |
| Q35868632 | Urinary protein-to-creatinine ratio in pregnant women after dipstick testing: prospective observational study |
| Q39836026 | Urinary protein-to-creatinine ratio indicative of significant proteinuria in normotensive pregnant women |
| Q46251419 | Vascular endothelial growth factor receptor 1 (Flt1) and apoptosis in the preeclamptic placenta and effects of in vivo anti-hypertensive exposure. |
| Q47702963 | What is the role of out-of-office BP measurement in hypertensive pregnancy? |
| Q58623926 | Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial |
Search more.